Research Article
Survival Benefit of Intervention Treatment in Advanced Anaplastic Thyroid Cancer
| | Characteristic | N (%) |
| | Gender | | | Female | 79 (65.3) | | Male | 42 (34.7) |
| | Age (years) | | | ≤40 | 3 (2.5) | | 41–50 | 6 (4.9) | | 51–60 | 23 (19.0) | | 61–70 | 49 (40.5) | | ≥70 | 40 (33.1) |
| | Underlying disease | | | No/Unknown | 88 (72.7) | | Diabetes mellitus | 19 (15.7) | | Hypertension | 17 (14.1) | | Dyslipidemia | 3 (2.5) | | Other | 15 (12.4) |
| | Thyroid function test | | | Hypothyroid | 8 (6.6) | | Euthyroid | 17 (14.1) | | Hyperthyroid | 3 (2.5) | | Unknown | 93 (76.9) |
| | WBC (cells/ml3) | | | ≥10,000 | 48 (39.7) | | <10,000 | 31 (25.6) | | Unknown | 42 (34.7) |
| | Tumor size (cm) | | | <5 | 6 (4.9) | | ≥5 | 88 (72.7) | | Unknown | 27 (22.3) | | Extrathyroid invasion involved vital structures | 14 (11.6) |
| | Cervical lymph node metastasis | | | No/Unknown | 69 (57.0) | | Unilateral single | 24 (19.8) | | Unilateral multiple | 18 (14.9) | | Bilateral | 10 (8.3) |
| | Distance metastasis | | | No/Unknown | 89 (71.8) | | Lung | 28 (22.6) | | Bone | 5 (4.0) | | Liver | 2 (1.6) |
| | Staging | | | IVa | 37 (30.6) | | IVb | 39 (32.2) | | IVc | 29 (23.9) | | Unknown | 16 (13.2) |
| | Treatment | | | Supportive treatment | 37 (30.6) | | Palliative radiation | 12 (9.9) | | Surgery alone | 29 (23.9) | | Chemoradiation | 9 (7.4) | | Surgery combined radiation | 13 (10.7) | | Surgery combined chemoradiation | 5 (4.1) | | Unknown | 16 (13.2) |
|
|
